-
HIDEN, IMP1, and FZD5 in Endoderm Differentiation
2026-09-01
Lu et al. identify HIDEN as a gene-desert lncRNA that supports human definitive endoderm differentiation by facilitating IMP1-dependent stabilization of FZD5 mRNA. The study links a distal noncoding transcript to WNT signaling and provides a framework for investigating lncRNA-mediated post-transcriptional regulation during stem-cell differentiation.
-
Pathogen-Adaptive Clues to Macrophage Bacterial Killing
2026-09-01
Russell et al. show that immune-adaptive variation in hypervirulent Streptococcus pneumoniae can reveal macrophage pathways that impose selective pressure on bacterial pathogens. Their validation of ACOD1/itaconate, NAMPT, and P2RX7, together with clemastine-mediated enhancement of phagolysosomal killing, provides a framework for identifying host-directed therapies against gram-positive infections.
-
Luminescent ATP Cell Viability Kit for Ferroptosis
2026-08-31
Use rapid ATP-based luciferase luminescence detection to quantify surviving cells in ferroptosis, proliferation, and cytotoxicity experiments. This practical workflow shows how the Luminescent ATP Cell Viability Assay Kit I can add sensitive, high-throughput viability data to mechanistic studies of ciprofloxacin and RSL3.
-
Fasudil (HA-1077) HCl: ROCK Workflow
2026-08-31
Learn how to deploy Fasudil (HA-1077) HCl as a ROCK inhibitor across migration, proliferation, apoptosis, and disease-model workflows. Practical dosing, assay design, and troubleshooting guidance help separate genuine Rho/ROCK pathway inhibition from solvent, density, and endpoint artifacts.
-
circRHOBTB3–NONO–MAOA Axis in Prostate Cancer
2026-08-30
A 2025 Cancer Letters study identifies circRHOBTB3 as a downregulated circular RNA that suppresses prostate cancer proliferation and metastasis by retaining NONO in the cytoplasm and reducing MAOA transcription. The work also connects circRNA biogenesis to SRSF9-mediated interactions with Alu elements, providing a mechanistic framework for biomarker development and metastasis-focused research.
-
NHE1, Olfr2, and Octanal-Driven Atherosclerosis
2026-08-29
This study identifies macrophage NHE1 as a downstream effector of octanal–Olfr2 signaling in atherosclerosis, linking receptor activation to calcium-dependent ROS production and NLRP3-associated inflammation. By combining ApoE−/− mice, RAW264.7 macrophages, pharmacological inhibition, RNA interference, and calcium chelation, the authors provide a mechanistic framework for understanding how lipid-peroxidation products amplify plaque pathology.
-
From RNA Structure to Translational Signal
2026-08-28
A mechanistic and strategic guide to using the HyperScript™ First-Strand cDNA Synthesis Kit when transcript structure, abundance, and assay design influence the interpretation of cancer biology data, illustrated through the PART1/miR-503-5p/FOXK1 axis in ovarian cancer.
-
Diclofenac in hiPSC Intestinal Organoid Assays
2026-08-28
Diclofenac provides a practical non-selective COX inhibitor tool for connecting prostaglandin biology with human intestinal absorption and metabolism studies. This workflow uses hiPSC-derived organoids to add barrier, transporter, and CYP3A context to cyclooxygenase inhibition assay design while highlighting key controls and troubleshooting steps.
-
Polybrene Workflows for p53Y220C Assays
2026-08-27
Polybrene can improve lentiviral, retroviral, and lipid-mediated DNA delivery when researchers are building reproducible cell models for mutant-p53 studies. This guide connects practical Hexadimethrine Bromide handling with assay controls inspired by a p53Y220C chemical-proximity study, while emphasizing cytotoxicity testing and experimental boundaries.
-
HyperFluor™ 488 Goat Anti-Human IgG: Assay Design
2026-08-27
Learn how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody supports rigorous human IgG detection across immunoassays. This guide connects fluorophore physics, species compatibility, and SARS-CoV-2 vaccine-study design to improve assay interpretation.
-
Nanoplastics–Cadmium Apoptosis via IP3R/Ca2+/STAT3
2026-08-26
A 2026 Toxicology study shows that combined polystyrene nanoplastic and cadmium exposure promotes intestinal apoptosis in C. elegans and Caco-2 cells through an IP3R/Ca2+/STAT3 signaling axis. Its inhibitor and calcium-chelation experiments position intracellular Ca2+ as a mechanistic mediator and provide a framework for interpreting co-contaminant toxicity in cell signaling studies.
-
Spatial Proteomics Maps PD-L1–IL-6 Crosstalk in PSC
2026-08-26
Orlandi and colleagues combine spatial proteomics with cell-cell cross-talk analysis to define how PD-L1 and IL-6 signals are organized at the epithelial–immune interface in human primary sclerosing cholangitis. The study provides a spatially resolved framework for generating mechanistic hypotheses while emphasizing that tissue associations require functional validation before they can support therapeutic conclusions.
-
E-4031: From hERG Blockade to Translational Insight
2026-08-25
E-4031 is more than a benchmark ion-channel reagent: it is a controlled perturbation tool for connecting hERG inhibition with action-potential instability, QT interval prolongation, and proarrhythmic substrate modeling. This article outlines how translational researchers can use the compound to build mechanistically coherent cardiac electrophysiology workflows while avoiding common interpretation and formulation errors.
-
Serine/Glycine Restriction, PD-L1 Lactylation, and CRC
2026-08-25
Tong et al. show that a serine/glycine-free diet can suppress colorectal cancer growth and strengthen cytotoxic T-cell activity while simultaneously promoting immune evasion through PD-L1 lactylation. The study combines preclinical mechanistic work with a single-arm phase I feasibility study, supporting dietary metabolic intervention as a potential adjunct to checkpoint blockade rather than as a stand-alone replacement for immunotherapy.
-
How p53 Loss Reprograms Macrophages via IL-34
2026-08-24
The 2024 Immunity study identifies an immune-escape circuit in which p53-inactivated liver cancer stem cells secrete IL-34, reprogram CD36-dependent foam-like macrophages, and suppress CD8+ T-cell activity. Its therapeutic experiments show that interrupting IL-34 signaling can sensitize these tumors to PD-1 blockade, while also defining important limits for translating the findings beyond the tested models.